On March 7, 2006, in room 2205 of the (then new) White Oak FDA facility, Prof. Trevor Marshall delivered a lecture in FDA's Center for Drug Evaluation and Review (CDER) "Visiting Professor" series. The topic was how ARBs and Statins affect a lot more of the body than just the receptors they are thought to target ('dirty drugs", in the words of one FDA participant).
A transcript of the presentation is available at:
A PDF copy of the slides is available at:
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?